65695-05-8(Methyl 4-(N-Hydroxycarbamimidoyl)benzoate) Price
This page is the exclusive Price page for 65695-05-8(Methyl 4-(N-Hydroxycarbamimidoyl)benzoate).
This page is dedicated to presenting you with the most accurate and real-time updated Price information about this important compound,thereby providing a strong basis for you when making relevant purchasing decisions and helping you understand the market Price dynamics more comprehensively and clearly.
Methyl 4-(N-Hydroxycarbamimidoyl)benzoate
C9H10N2O3
194.187302112579
MFCD08689689
517652
Methyl 4-(N-Hydroxycarbamimidoyl)benzoate Price
| Related Categories | No. | Brand | Purity | Specification | Price | Update time | Buy |
|---|---|---|---|---|---|---|---|
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 046883-1g | jiu ding | >95% | 1g | 2307CNY | 08 May. 2021 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 046883-500mg | jiu ding | >95% | 500mg | 1495CNY | 08 May. 2021 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 046883-5g | jiu ding | >95% | 5g | 5900CNY | 08 May. 2021 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-NF246-250mg | jiu ding | 97% | 250mg | 415CNY | 08 May. 2021 | |
| Alichem | A019097165-5g | alichem | 97% | 5g | 237.60 USD | 17 Jun. 2021 | |
| Alichem | A019097165-10g | alichem | 97% | 10g | 401.70 USD | 17 Jun. 2021 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 046883-1g | jiu ding | >95% | 1g | 2307.0CNY | 13 Jul. 2021 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 046883-500mg | jiu ding | >95% | 500mg | 1495.0CNY | 13 Jul. 2021 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 046883-5g | jiu ding | >95% | 5g | 5900.0CNY | 13 Jul. 2021 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-NF246-50mg | jiu ding | 97% | 50mg | 56.0CNY | 13 Jul. 2021 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-NF246-5g | jiu ding | 97% | 5g | 950.0CNY | 13 Jul. 2021 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-NF246-1g | jiu ding | 97% | 1g | 271.0CNY | 13 Jul. 2021 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-NF246-200mg | jiu ding | 97% | 200mg | 86.0CNY | 13 Jul. 2021 | |
| TRC | M321340-25mg | trc | 25mg | $ 50.00 | 04 Jun. 2022 | ||
| TRC | M321340-50mg | trc | 50mg | $ 65.00 | 04 Jun. 2022 | ||
| TRC | M321340-250mg | trc | 250mg | $ 95.00 | 04 Jun. 2022 | ||
| Enamine | EN300-72378-0.05g | enaminestore | 95% | 0.05g | $22.0 | 12 Feb. 2023 | |
| Enamine | EN300-72378-0.1g | enaminestore | 95% | 0.1g | $34.0 | 12 Feb. 2023 | |
| Enamine | EN300-72378-0.25g | enaminestore | 95% | 0.25g | $47.0 | 12 Feb. 2023 | |
| Enamine | EN300-72378-0.5g | enaminestore | 95% | 0.5g | $75.0 | 12 Feb. 2023 | |
| Enamine | EN300-72378-1.0g | enaminestore | 95% | 1.0g | $96.0 | 12 Feb. 2023 | |
| Enamine | EN300-72378-2.5g | enaminestore | 95% | 2.5g | $184.0 | 12 Feb. 2023 | |
| Enamine | EN300-72378-5.0g | enaminestore | 95% | 5.0g | $331.0 | 12 Feb. 2023 | |
| Enamine | EN300-72378-10.0g | enaminestore | 95% | 10.0g | $654.0 | 12 Feb. 2023 | |
| abcr | AB303854-250 mg | abcr | 95% | 250mg | €77.40 | 26 Apr. 2023 | |
| abcr | AB303854-1 g | abcr | 95% | 1g | €98.30 | 26 Apr. 2023 | |
| abcr | AB303854-5 g | abcr | 95% | 5g | €181.70 | 26 Apr. 2023 | |
| abcr | AB303854-25 g | abcr | 95% | 25g | €417.10 | 26 Apr. 2023 | |
| Aaron | AR00FCVF-5g | aaron | 97% | 5g | $88.00 | 13 Dec. 2023 | |
| SHANG HAI BI DE YI YAO KE JI GU FEN Co., Ltd. | BD138859-250mg | bi de | 97% | 250mg | ¥65.0 | 18 Apr. 2024 |
Recommended suppliers
ASIACHEM I&E (JIANGSU) CO., LTD
Audited Supplier
Gold Member
CN Supplier
Bulk
Company nature: Private enterprises
Shenzhen Jianxing Pharmaceutical Technology Co., Ltd.
Audited Supplier
Gold Member
CN Supplier
Reagent
Company nature: Private enterprises
Henan Dongyan Pharmaceutical Co., Ltd
Audited Supplier
Gold Member
CN Supplier
Bulk
Company nature: Private enterprises
Shenzhen GeneSeqTools Bioscience & Technology Co. Ltd.
Audited Supplier
Gold Member
CN Supplier
Reagent
Company nature: Private enterprises
Essenoi Fine Chemical Co., Limited
Audited Supplier
Gold Member
CN Supplier
Reagent
Company nature: Private enterprises